Osaka, Japan, June 26, 2015 --- Takeda Pharmaceutical Company Limited today announced new assignment of Directors. The details are as follows;

ž・New assignment of Directors effective June 26, 2015;
New assignment Previous assignment Name

Director,
Chairman of the Board

(Representative Director, Chairman of the Board Yasuchika Hasegawa
Director,
Chief Medical and Scientific Officer
(Corporate Officer) Andrew Plump, M.D., Ph.D.
Corporate Auditor (Managing Director) Yasuhiko Yamanaka

###

distributed by